Navigation Links
InVitria's Better Ingredients for Better Media to be Showcased at BPI '09
Date:10/1/2009

InVitria's new cell culture media supplements, Zap-CHO and Optiferrin, have been developed to maximize cell culture media performance and will be on display at BioProcess International '09, the premier event for the bioprocessing industry, October 12-16 at Raleigh Convention Center in Raleigh, North Carolina.

Fort Collins, CO (PRWEB) October 1, 2009 -- As conference exhibitor and poster presenter, InVitria will highlight the recent launch of two new products -- Zap-CHO and Optiferrin. These products add to InVitria's product line and will be part of its "Better Ingredients for Better Media" promotion at BPI '09.

InVitria's media supplements are gaining significant traction in the cell culture media and biomanufacturing industry and will be on display at BioProcess International Conference and Exhibition in Raleigh, North Carolina, October 12-16.

Further, InVitria will be hosting a pizza party where attendees can learn more about InVitria's completely animal free and high performance product line. Visitors to InVitria's exhibit booth #1011 can pick up an invitation to the pizza party and learn more about InVitria's exciting product line.

Zap-CHO
Zap-CHO is a defined and animal free CHO (Chinese hamster ovaries) cell culture supplement capable of replacing fetal bovine serum (FBS) while still maintaining maximum cell performance. Zap-CHO is also an alternative to using hydrolysates in cell culture media optimization because it is a well-defined supplement which reduces variability and production failures. Zap-CHO is ideal for use with commercial, chemically-defined and serum- and animal free cell culture media formulations.

Optiferrin
Optiferrin is a cell culture media supplement which supports cell growth by regulating the amount of iron transported to the cell. Since iron is required for healthy cell culture performance, it is a critical component to reach optimal performance. InVitria's Optiferrin is animal free, so it is a safe and effective alternative to using iron chelators and elemental iron in media formulations. InVitria customers have utilized Optiferrin to provide the essential amount of iron for optimal results.

About InVitria
InVitria develops, manufactures and markets a portfolio of high performance and well defined cell culture media components and reagents used in bioprocessing, biopharmaceutical formulation, stem cell & regenerative medicine, life science research, medical devices and diagnostics.

For more information about InVitria's newest products, Zap-CHO and Optiferrin, and to order InVitria products please contact InVitria at info(at)invitria(dot)com or call 1-800-916-8311. Orders may be placed online using a credit card at www.InVitria.com.

###

Read the full story at http://www.prweb.com/releases/Zap-CHO/Optiferrin/prweb2974734.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. InVitria's Cell Culture Media Components Showcased at WilBio's 2008 Cell Engineering Meeting
2. InVitria's Cellastim Delivers Superior Results in CHO Cell Culture
3. Older Women May Sleep Better Than Men
4. Study shows that elderly women sleep better than they think, men sleep worse
5. Pelosi: Health Reform Will Provide Seniors Better Benefits, Guaranteed Access to Doctors, Extended Stability for Medicare
6. Chronic pain treatments work better together, says anesthesiologist
7. Henry Ford Macomb Hospital Deploys PerfectServe at Warren Campus to Improve Communication, Better Coordinate Care
8. Sexually satisfied women have better general well-being and more vitality
9. Women fare better than men with metastatic colorectal cancer -- are hormones helping?
10. UNC expert: Better decision support tools needed for prostate cancer screening choice
11. Drug-eluting stents better than bare-metal stents for heart attack patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2017)... , ... July 24, 2017 , ... A CDC study shows that, although people are ... Caucasians (ages 18 to 29), had at least one case of sunburn within the past ... which causes people to ignore the issue. However, only recently have people become conscientious of ...
(Date:7/24/2017)... ... July 24, 2017 , ... The 2017 NCSL International Workshop ... theme focuses on the new ISO/IEC 17025 standards. This marks the first time ... and calibration will be changed. , As an exhibitor, METTLER TOLEDO will ...
(Date:7/24/2017)... ... July 24, 2017 , ... Paul Vitenas, MD, FACS is excited ... plastic surgeons, invited to attend Allergan’s recent meeting with their Plastics Advisory Board. As ... the world, Allergan is bringing a newly defined structure to the aesthetics market. ...
(Date:7/24/2017)... , ... July 24, 2017 , ... ... CURE announced that they have enrolled over 100,000 children in their treatment program. ... born every year in areas where treatment is limited or non-existent. Without intervention, ...
(Date:7/24/2017)... Church, VA (PRWEB) , ... July 24, 2017 ... ... figuring out how to change manufacturers future. , The agency is hammering out ... Cures Act, one of the farthest-ranging laws ever to affect FDA-regulated firms. The ...
Breaking Medicine News(10 mins):
(Date:7/14/2017)... plc (NASDAQ: ENDP ) will announce its second-quarter 2017 ... management team will host a conference call and webcast before the ... The dial-in number to access the call is U.S./ Canada ... 45397076. Please dial in 10 minutes prior to the scheduled start ... the call will be available from August 8, 2017 at 11:30 ...
(Date:7/13/2017)... July 13, 2017 RK Logistics Group, Inc. was ... certification for its Fremont, CA headquarters ... the Tri-Valley and San Jose for ... of Fremont , with its Fremont Innovation District, is ... such a powerful resource to the hundreds of biotech, pharma ...
(Date:7/12/2017)... Lilly and Company (NYSE: LLY ) has entered ... patent litigation in the U.S. District Court for the Eastern ... ® (tadalafil) unit dose patent. This patent was previously ... the agreement, Cialis exclusivity is now expected to end at ... dose patent for Cialis is valid and infringed by companies ...
Breaking Medicine Technology: